Monday, November 30, 2020 7:26:44 PM
https://www.hiv.gov/events/awareness-days
Imo possibly one of the best possibilities to treat aids and covid.
Merger with...
BioClonetics is in the final stage of development of a parent monoclonal antibody ("mAbs") (designated as Clone 3), which is non-toxic and has shown in initial in vitro testing to be effective against more than 95% of all strains and viral subtypes of HIV-1 against which it has been tested.
“ENZC is in the process of compiling the information to bring current its OTC filings. “
From 10/21-11/24 (11 filings filed!!!)
Current soon!!
https://finance.yahoo.com/news/enzolytics-inc-announces-execution-binding-130000888.html
https://www.otcmarkets.com/stock/ENZC/disclosure
On December 1, we are expanding our lab to the campus of Texas A&M University at its Institute for Preclinical Studies.
https://finance.yahoo.com/news/enzolytics-inc-shares-current-bioclonetics-140000939.html
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • NGTF • Oct 1, 2024 8:30 AM
ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM